Urticaria as a first clinical manifestation of COVID-19

Eur J Dermatol. 2020 Dec 1;30(6):737-738. doi: 10.1684/ejd.2020.3907.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acetaminophen / therapeutic use
  • Adult
  • Antiviral Agents / therapeutic use
  • COVID-19 / diagnosis*
  • COVID-19 Drug Treatment
  • Cetirizine / therapeutic use
  • Dermatologic Agents / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Histamine H1 Antagonists, Non-Sedating / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Male
  • Middle Aged
  • SARS-CoV-2
  • Urticaria / drug therapy
  • Urticaria / virology*

Substances

  • Antiviral Agents
  • Dermatologic Agents
  • Histamine H1 Antagonists, Non-Sedating
  • Acetaminophen
  • Hydroxychloroquine
  • Cetirizine